Heron Therapeutics Inc (HRTX)

May 14, 2025

J. Goldman & Co LP Acquires Shares of 270,100 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

May 14, 2025

May 14, 2025

300,000 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Bought by Bridgeway Capital Management LLC - MarketBeat

May 14, 2025

May 14, 2025

What is Northland Capmk's Estimate for HRTX Q2 Earnings? - MarketBeat

May 14, 2025

May 13, 2025

Clearline Capital LP Has $2.77 Million Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

May 13, 2025

May 12, 2025

Heron Therapeutics (NASDAQ:HRTX) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

May 12, 2025

May 11, 2025

Heron Therapeutics Sees Unusually Large Options Volume (NASDAQ:HRTX) - MarketBeat

May 11, 2025

May 09, 2025

Results: Heron Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

May 09, 2025

May 09, 2025

Heron Therapeutics, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st

May 09, 2025

May 07, 2025

Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025 (NASDAQ:HRTX) - Seeking Alpha

May 07, 2025

May 07, 2025

Heron settles patent dispute with Viatris over antiemetic agents - MSN

May 07, 2025

May 07, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

May 07, 2025

Heron Therapeutics First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 07, 2025

May 07, 2025

Heron Therapeutics Reports Strong Q1 2025 Results - TipRanks

May 07, 2025

May 06, 2025

Heron Therapeutics Q1 2025 Earnings: Strong Growth Amid Challenges - TipRanks

May 06, 2025

May 06, 2025

Heron Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 06, 2025

May 06, 2025

Heron Therapeutics (HRTX) Resolves Patent Dispute with Viatris - GuruFocus

May 06, 2025

May 06, 2025

Heron Settles Patent Litigation With Mylan Over Cinvanti, Aponvie; Shares Rise - marketscreener.com

May 06, 2025

May 06, 2025

Heron stock up as Viatris patent dispute ends (HRTX:NASDAQ) - Seeking Alpha

May 06, 2025

May 06, 2025

Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

May 06, 2025

May 06, 2025

Earnings call transcript: Heron Therapeutics beats Q1 2025 expectations, stock surges - Investing.com Canada

May 06, 2025

May 06, 2025

Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates - Yahoo Finance

May 06, 2025

May 06, 2025

HRTX Achieves Record Q1 Revenue, Surpassing Expectations | HRTX Stock News - GuruFocus

May 06, 2025

May 06, 2025

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates - The Malaysian Reserve

May 06, 2025

May 06, 2025

Heron Therapeutics (HRTX) Settles Patent Disputes with Mylan Pharmaceuticals | HRTX Stock News - GuruFocus

May 06, 2025

May 06, 2025

Heron Therapeutics Q1 2025 Financial Results - TradingView

May 06, 2025

May 06, 2025

Heron Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 06, 2025

May 06, 2025

Heron Therapeutics settles patent litigation with Mylan By Investing.com - Investing.com India

May 06, 2025

May 06, 2025

Heron Therapeutics Announces Settlement With Mylan Related To Cinvanti® And Aponvie® Patent Litigations - marketscreener.com

May 06, 2025

May 06, 2025

Heron Therapeutics Wins 7-Year Market Exclusivity in Patent Settlement with Mylan - Stock Titan

May 06, 2025

May 06, 2025

Invesco Ltd. Grows Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

May 06, 2025

May 05, 2025

Heron Therapeutics (HRTX) Awaits Q1 Earnings Report - GuruFocus

May 05, 2025

May 05, 2025

Marshall Wace LLP Cuts Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

May 05, 2025

May 04, 2025

Heron Therapeutics (HRTX) Projected to Post Earnings on Tuesday - MarketBeat

May 04, 2025

May 03, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat

May 03, 2025

May 03, 2025

Adage Capital Partners GP L.L.C. Decreases Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

May 03, 2025

May 02, 2025

Renaissance Technologies LLC Has $1.82 Million Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

May 02, 2025

May 02, 2025

Heron Therapeutics Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView

May 02, 2025

May 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by LPL Financial LLC - Defense World

May 02, 2025

May 01, 2025

Healthy Upside Potential: Heron Therapeutics Inc (HRTX) - Sete News

May 01, 2025

Apr 29, 2025

American Society of Anesthesiologists Announces Heron Therapeutics as Industry Supporter for Seventh Year | Newswise - Newswise

Apr 29, 2025

Apr 29, 2025

HRTX stock rated a Buy by Rodman & Renshaw - knoxdaily.com

Apr 29, 2025

Apr 29, 2025

It would be worthwhile to take a closer look at Heron Therapeutics Inc (HRTX) - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance

Apr 29, 2025

Apr 29, 2025

Heron Therapeutics Appoints Mark Hensley as COO - TipRanks

Apr 29, 2025

Apr 29, 2025

Heron Therapeutics Names Mark Hensley as COO - marketscreener.com

Apr 29, 2025